Amphastar Pharma
AMPH----
Amphastar Pharma (AMPH)
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and in...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Amphastar Pharma Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$22.0017.52%
Forecast & RatingHold
7analysts
- Strong buy0.00%
- Buy0.00%
- Hold85.71%
- Sell0.00%
- Strong sell14.29%
News
- benzinga_article · 2 days ago, 05:25 AM
Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
- Tip Ranks · Jul 23 at 08:36 AM
Amphastar Pharmaceuticals (AMPH) Gets a Hold from J.P. Morgan
- PUBT · Jul 13 at 06:36 PM
Amphastar Pharmaceuticals director Anthony T. Pierce files initial beneficial ownership statement (Form 3)
- PUBT · Jul 13 at 05:07 AM
Amphastar names Anthony Pierce to board as director expands to 11 seats
- TradingView · Jul 8 at 05:03 AM
Amphastar Pharmaceuticals subsidiary receives FDA warning letter over CGMP issues at California facility
- TradingView · Jun 29 at 08:20 AM
Amphastar Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $22, Implies 1% Upside
